Concentrics Research

Clinical Research

For nearly 30 years, Concentrics Research has been a leader in the conduct of Rx-to-OTC Switch and late-stage (Phase II-IV) research for the pharmaceutical, biotechnology, medical device, nutritional, and consumer healthcare product industries. With significant funding from Bindley Capital, Concentrics is committed to growth and innovation. This results in a continuous improvement in service offerings for our clients.